UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 10, 2006
ENDOCARE, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-15063
|
|
33-0618093 |
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number) |
201 Technology Drive
Irvine, California 92618
(Address of Principal Executive Offices, including zip code)
(949) 450-5400
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 7.01 Regulation FD Disclosure.
Attached as Exhibit 99.1 are slides prepared for use in connection with the C.E. Unterberg Towbin
Emerging Growth Opportunities Conference to be held July 11-12, 2006.
This Form 8-K, the information contained herein, and the attached exhibit are furnished to, but not
filed with, the Securities and Exchange Commission. The information contained herein and in the
accompanying exhibit shall not be incorporated by reference to any filing of the Company, whether
made before or after the date hereof, regardless of any general incorporation language in such
filing, unless expressly incorporated by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
The exhibit listed below is being furnished with this Form 8-K.
| |
99.1 |
|
Slides prepared for use in connection with the C.E. Unterberg Towbin Emerging
Growth Opportunities Conference. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
|
ENDOCARE, INC. |
|
|
|
|
|
July 10, 2006
|
|
By:
|
|
/s/ Michael R. Rodriguez |
|
|
|
|
|
|
|
|
|
Michael R. Rodriguez |
|
|
|
|
Senior Vice President, Finance |
|
|
|
|
and Chief Financial Officer |